Printer Friendly

HOLOGIC, INC. ANNOUNCES THIRD QUARTER 1993 RESULTS

 WALTHAM, Mass., July 30 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced its results for the third quarter ending June 26, 1993, reporting a net loss of $168,894, or 4 cents per share, compared with net income of $653,731 or 16 cents per share, for the third quarter of fiscal 1992. Third quarter total revenues were $6,633,744 compared to $7,364,993 for the third quarter of fiscal 1992 and $6,430,182 for the second quarter of fiscal 1993.
 The net loss for the nine months ended June 26, 1993 totaled $819,560 or 21 cents per share, as compared to net income of $1,457,054, or 36 cents per share, for the nine months ended June 30, 1992. Total revenues decreased to $18,504,500 for the current nine month period when compared to $19,084,353 for the corresponding nine month period in 1992.
 "During the quarter we continued to focus on increasing sales activity in our new and established markets. Even though the market for medical devices remains sluggish, these efforts resulted in a slight increase in revenues when compared to the second quarter of 1993," said S. David Ellenbogen, president and CEO. "This increase in revenue was offset by higher marketing expenses associated with the development of new sales territories in areas such as South America and the Pacific Rim. Although these expenses impacted our profitability, we feel that they represent a prudent investment in light of the future sales potential in these territories."
 Ellenbogen also reported that during the quarter Hologic Europe signed a distribution agreement with Soredex, S.A., a wholly-owned subsidiary of Orion Corporation (Helsinki, Finland). Under the terms of this agreement, Hologic Europe will act as the European distributor for "Scanora," a specialized system for taking x-rays of the teeth and jaw. The Scanora system supports more than 1,000 different image modes, including pre-surgical planning of dental implants, reconstructive surgery and temporal mandibular joint repair. Dental implant procedures have experienced a significant growth over the past five years, a trend expected to continue in the future. Scanora provides Hologic with a second unique niche in the medical imaging market.
 Hologic, Inc. develops, manufactures and markets proprietary x-ray systems. With more than 1,500 installations worldwide, the company's QDR and DTX bone densitometers are used for the precise measurement of bone density to assist in the diagnosis and monitoring of osteoporosis and other metabolic bone diseases. Osteoporosis, a condition characterized by decreased bone density and increased risk of fractures, occurs in at least one of three women over the age of 65.
 A consolidated statement of income and balance sheet for the company is attached.
 HOLOGIC, INC. AND SUBSIDIARIES
 CONSOLIDATED STATEMENTS OF INCOME
 (Unaudited)
 Three Months Ended Nine Months Ended
 June 26, June 30, June 26, June 30,
 1993 1992 1993 1992
 REVENUES:
 Product sales $6,407,495 $7,364,993 $17,965,008 $19,084,353
 Other income 226,249 --- 539,492 ---
 Total 6,633,744 7,364,993 18,504,500 19,084,353
 COSTS AND EXP
 Cost of product
 sales 3,629,685 3,846,758 10,065,375 9,753,078
 Research and
 development 759,153 930,021 2,310,475 2,598,044
 Selling and
 marketing 1,507,833 1,301,759 4,278,691 3,101,655
 General and
 administrative 927,801 691,239 2,657,295 2,174,255
 Total 6,824,472 6,769,777 19,311,836 17,627,032
 Income (loss) from
 operations (190,728) 595,216 (807,336) 1,457,321
 Interest income 66,088 128,026 229,084 412,244
 Other income (expense) (44,254) 210,489 (405,308) 210,489
 Income (loss) before
 provision (benefit)
 for income taxes (168,894) 933,731 (983,560) 2,080,054
 PROVISION (BENEFIT) FOR
 INCOME TAXES --- 280,000 (164,000) 623,000
 Net income (loss) $(168,894) $653,731 $(819,560) $1,457,054
 NET INCOME (LOSS) PER
 COMMON AND COMMON
 EQUIVALENT SHARE: (4 cents) 16 cents (21 cents) 36 cents
 WEIGHTED AVERAGE NUMBER
 OF COMMON AND COMMON
 EQUIVALENT SHARES
 OUTSTANDING: 3,938,498 4,057,624 3,924,547 4,053,928
 HOLOGIC, INC. AND SUBSIDIARIES
 Consolidated Balance Sheets
 (Unaudited)
 ASSETS
 June 26, Sept. 30,
 1993 1992
 CURRENT ASSETS:
 Cash and cash equivalents $6,314,444 $2,369,978
 Short-term investments 3,930,201 8,177,096
 Accounts receivable,
 less reserve of $150,000
 and $125,000 respectively 5,627,241 5,157,666
 Inventories 3,750,609 4,313,216
 Prepaid expenses and
 other current assets 695,184 986,642
 Total current assets 20,317,679 21,004,598
 PROPERTY AND EQUIPMENT, at cost:
 Equipment 1,466,708 1,427,739
 Furniture and fixtures 492,694 441,359
 Leasehold improvements 349,204 362,178
 Total 2,308,606 2,231,276
 Less - Accumulated depreciation
 and amortization 1,155,178 874,643
 Total 1,153,428 1,356,633
 OTHER ASSETS, net 608,887 333,386
 Total $22,079,994 $22,694,617
 LIABILITIES AND STOCKHOLDERS' EQUITY
 June 26, Sept. 30,
 1993 1992
 CURRENT LIABILITIES:
 Accounts payable $1,799,928 $1,476,897
 Accrued expenses 2,112,703 2,314,981
 Deferred revenue 862,859 785,979
 Total current liabilities 4,775,490 4,577,857
 STOCKHOLDERS' EQUITY:
 Common stock, $.01 par value-
 Authorized - 10,000,000 shares
 Issued and outstanding - 3,946,292
 and 3,906,100 shares at
 June 26, 1993 and Sept. 30, 1992
 respectively 39,463 39,061
 Capital in excess of par value 13,884,317 13,824,437
 Retained earnings 3,511,177 4,330,737
 Cumulative translation adjustment (130,453) (77,475)
 Total stockholders' equity 17,304,504 18,116,760
 Total $22,079,994 $22,694,617
 -0- 7/29/93
 /CONTACT: S. David Ellenbogen, president, or Glenn Muir, vice president/finance, both of Hologic, Inc., 617-890-2300/
 (HOLX)


CO: Hologic, Inc. ST: Massachusetts IN: MTC SU: ERN

JL -- NE003 -- 7594 07/30/93 08:21 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 30, 1993
Words:997
Previous Article:THE FOOTHILL GROUP INC. DECLARES QUARTERLY DIVIDEND OF 3 CENTS PER SHARE
Next Article:A. L. LABORATORIES REPORTS SECOND QUARTER AND SIX MONTH RESULTS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters